...
首页> 外文期刊>The Journal of general physiology >Propofol inhibits the voltage-gated sodium channel NaChBac at multiple sites
【24h】

Propofol inhibits the voltage-gated sodium channel NaChBac at multiple sites

机译:异丙酚在多个位点抑制电压门控钠通道NaChBac

获取原文
   

获取外文期刊封面封底 >>

       

摘要

General anesthetics inhibit voltage-gated sodium channels by unknown molecular mechanisms. Using computation-guided NMR and electrophysiology analyses, Wang et al. show that propofol binds to the prokaryotic sodium channel NaChBac at multiple distinct sites. Voltage-gated sodium (Na _(V)) channels are important targets of general anesthetics, including the intravenous anesthetic propofol. Electrophysiology studies on the prokaryotic Na _(V) channel NaChBac have demonstrated that propofol promotes channel activation and accelerates activation-coupled inactivation, but the molecular mechanisms of these effects are unclear. Here, guided by computational docking and molecular dynamics simulations, we predict several propofol-binding sites in NaChBac. We then strategically place small fluorinated probes at these putative binding sites and experimentally quantify the interaction strengths with a fluorinated propofol analogue, 4-fluoropropofol. In vitro and in vivo measurements show that 4-fluoropropofol and propofol have similar effects on NaChBac function and nearly identical anesthetizing effects on tadpole mobility. Using quantitative analysis by ~(19)F-NMR saturation transfer difference spectroscopy, we reveal strong intermolecular cross-relaxation rate constants between 4-fluoropropofol and four different regions of NaChBac, including the activation gate and selectivity filter in the pore, the voltage sensing domain, and the S4–S5 linker. Unlike volatile anesthetics, 4-fluoropropofol does not bind to the extracellular interface of the pore domain. Collectively, our results show that propofol inhibits NaChBac at multiple sites, likely with distinct modes of action. This study provides a molecular basis for understanding the net inhibitory action of propofol on Na _(V) channels.
机译:全身麻醉药通过未知的分子机制抑制电压门控性钠通道。使用计算指导的NMR和电生理分析,Wang等。表明丙泊酚在多个不同位点与原核钠通道NaChBac结合。电压门控钠(Na_(V))通道是全身麻醉的重要目标,包括静脉麻醉药异丙酚。对原核生物Na_(V)通道NaChBac的电生理研究表明,异丙酚可促进通道激活并加速激活偶联的失活,但这些作用的分子机制尚不清楚。在这里,在计算对接和分子动力学模拟的指导下,我们预测了NaChBac中的几个异丙酚结合位点。然后,我们策略性地将小型氟化探针放置在这些假定的结合位点上,并通过实验量化与氟化丙泊酚类似物4-氟丙泊酚的相互作用强度。体外和体内测量显示,4-氟丙泊酚和丙泊酚对NaChBac功能具有相似的作用,而对t的活动性具有几乎相同的麻醉作用。使用〜(19)F-NMR饱和转移差分光谱法进行的定量分析,我们揭示了4-氟丙泊酚与NaChBac的四个不同区域之间的强分子间交叉弛豫速率常数,包括孔中的激活门和选择性滤光片,电压感应域和S4–S5链接器。与挥发性麻醉剂不同,4-氟丙泊酚不与孔结构域的细胞外界面结合。总的来说,我们的研究结果表明,异丙酚在多个部位抑制NaChBac,可能具有不同的作用方式。该研究为理解异丙酚对Na_(V)通道的净抑制作用提供了分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号